Edesa Biotech (EDSA) Short Interest Ratio & Short Volume $2.00 -0.03 (-1.48%) Closing price 05/21/2025 03:46 PM EasternExtended Trading$1.98 -0.01 (-0.75%) As of 05/21/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Edesa Biotech Short Interest DataEdesa Biotech (EDSA) has a short interest of 41,000 shares, representing 0.68% of the float (the number of shares available for trading by the public). This marks a -24.77% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 490,387 shares to cover all short positions.Current Short Interest41,000 sharesPrevious Short Interest54,500 sharesChange Vs. Previous Month-24.77%Dollar Volume Sold Short$95,530.00Short Interest Ratio0.0 Days to CoverLast Record DateApril 30, 2025Outstanding Shares7,023,000 sharesFloat Size6,060,000 sharesShort Percent of Float0.68%Today's Trading Volume18,701 sharesAverage Trading Volume490,387 sharesToday's Volume Vs. Average4% Short Selling Edesa Biotech? Sign up to receive the latest short interest report for Edesa Biotech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartEDSA Short Interest Over TimeEDSA Days to Cover Over TimeEDSA Percentage of Float Shorted Over Time Edesa Biotech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202541,000 shares $95,530.00 -24.8%0.7%0 $2.33 4/15/202554,500 shares $126,712.50 -25.4%0.9%0 $2.33 3/31/202573,100 shares $178,364.00 -25.0%1.2%0 $2.44 3/15/202597,400 shares $232,786.00 -9.2%1.6%0.1 $2.39 2/28/2025107,300 shares $234,987.00 -87.4%1.8%0.1 $2.19 2/15/2025852,100 shares $2.29 million +4,942.0%15.5%0.5 $2.69 1/31/202516,900 shares $32,194.50 +259.6%0.7%0.6 $1.91 1/15/20254,700 shares $8,225.00 -14.6%0.2%0.1 $1.75 12/31/20245,500 shares $9,240.00 -74.4%0.2%0.2 $1.68 12/15/202421,500 shares $41,626.15 -39.4%0.9%0.7 $1.94 Get the Latest News and Ratings for EDSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Edesa Biotech and its competitors with MarketBeat's FREE daily newsletter. 11/30/202435,500 shares $86,620.00 -26.8%1.6%1.2 $2.44 11/15/202448,500 shares $101,850.00 +192.2%2.2%2.1 $2.10 10/31/202416,600 shares $54,780.00 -16.2%0.8%0.8 $3.30 10/15/202419,800 shares $82,364.04 +58.4%0.9%1.9 $4.16 9/30/202412,500 shares $55,625.00 -25.6%0.6%1.3 $4.45 9/15/202416,800 shares $73,399.20 +14.3%0.8%2.1 $4.37 8/31/202414,700 shares $66,150.00 -8.7%0.7%1.8 $4.50 8/15/202416,100 shares $69,552.00 -12.5%0.7%1.5 $4.32 7/31/202418,400 shares $97,520.00 +2.8%0.8%1.7 $5.30 7/15/202417,900 shares $75,717.00 -0.6%0.8%2 $4.23 6/30/202418,000 shares $77,040.00 +13.9%0.8%2.2 $4.28 6/15/202415,800 shares $70,298.94 +6.8%0.7%1.7 $4.45 5/31/202414,800 shares $64,084.00 +32.1%0.7%1.7 $4.33 5/15/202411,200 shares $50,512.00 -30.4%0.5%1.3 $4.51 4/30/202416,100 shares $71,532.30 +5.9%0.7%1.5 $4.44 4/15/202415,200 shares $62,624.00 -22.1%0.7%1.2 $4.12 3/31/202419,500 shares $81,738.15 +10.2%0.8%1.4 $4.19 3/15/202417,700 shares $77,703.00 +4.1%0.8%1.2 $4.39 2/29/202417,000 shares $77,860.00 +11.8%0.7%0.6 $4.58 2/15/202415,200 shares $85,880.00 -27.6%0.7%0.5 $5.65 1/31/202421,000 shares $93,450.00 +2,525.0%0.9%0.7 $4.45 1/15/2024800 shares $3,728.00 -93.4%0.0%0 $4.66 12/31/202312,100 shares $55,297.00 -61.7%0.5%0.1 $4.57 12/15/202331,600 shares $164,004.00 +1,404.8%1.4%0.3 $5.19 11/30/20232,100 shares $6,930.00 -91.0%0.1%0 $3.30 11/15/202323,200 shares $67,280.00 -21.6%1.1%0.3 $2.90 10/31/202329,600 shares $95,312.00 -50.3%1.4%0.4 $3.22 10/15/202359,500 shares $235,322.50 -80.2%2.8%0.8 $3.96 9/30/2023300,200 shares $1.33 million -4.9%N/A3.5 $4.42 9/15/2023315,500 shares $283,950.00 -0.9%N/A6.5 $0.90Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 8/31/2023318,200 shares $269,515.40 -49.7%N/A5.8 $0.85 8/15/2023632,100 shares $537,285.00 -1.4%N/A11.5 $0.85 7/31/2023641,300 shares $525,866.00 -0.1%N/A10.8 $0.82 7/15/2023641,700 shares $534,471.93 -3.2%N/A8.9 $0.83 6/30/2023662,800 shares $530,240.00 +5.0%N/A9.6 $0.80 6/15/2023631,000 shares $542,218.30 -0.1%N/A8.7 $0.86 5/31/2023631,800 shares $574,938.00 -1.2%N/A7.9 $0.91 5/15/2023639,600 shares $562,911.96 -12.4%N/A8 $0.88 4/30/2023730,500 shares $818,160.00 -20.0%N/A8.6 $1.12 4/15/2023913,300 shares $958,965.00 +0.8%N/A9.5 $1.05 3/31/2023906,500 shares $826,818.65 +10.9%N/A4.9 $0.91 3/15/2023817,300 shares $980,760.00 +19.3%N/A1.7 $1.20 2/28/2023685,300 shares $979,979.00 +6.3%N/A1.4 $1.43 2/15/2023644,500 shares $928,080.00 -17.6%N/A1.3 $1.44 1/31/2023781,700 shares $1.17 million +16.7%N/A1.6 $1.50 1/15/2023669,600 shares $1.69 million -17.8%N/A1.4 $2.52 12/30/2022815,000 shares $1.76 million +111.0%N/A2.1 $2.16 12/15/2022386,300 shares $370,732.11 +4.4%3.2%0.9 $0.96 11/30/2022369,900 shares $341,121.78 +4.3%3.9%1.9 $0.92 11/15/2022354,800 shares $325,316.12 +6.2%3.7%1.8 $0.92 10/31/2022334,000 shares $344,020.00 +10.5%3.5%1.7 $1.03 10/15/2022302,300 shares $292,535.71 +484.7%3.0%1.5 $0.97 9/30/202251,700 shares $47,631.21 -38.7%0.5%0.3 $0.92 9/15/202284,300 shares $148,368.00 -11.9%0.8%1.2 $1.76 8/31/202295,700 shares $179,916.00 +476.5%1.0%1.3 $1.88 8/15/202216,600 shares $32,536.00 -73.7%0.2%0.2 $1.96 7/31/202263,000 shares $113,400.00 -5.8%0.6%0.9 $1.80 7/15/202266,900 shares $109,716.00 -22.9%0.7%1.2 $1.64 6/30/202286,800 shares $139,748.00 -26.4%0.9%1.4 $1.61 6/15/2022117,900 shares $200,430.00 +12.7%1.2%2 $1.70 5/31/2022104,600 shares $215,476.00 -18.9%1.0%1.5 $2.06 5/15/2022129,000 shares $241,230.00 -13.4%1.3%1.8 $1.87 4/30/2022149,000 shares $330,780.00 -1.9%1.6%2.1 $2.22 4/15/2022151,900 shares $429,877.00 +13.7%1.6%2 $2.83 3/31/2022133,600 shares $396,792.00 -42.7%1.5%1.5 $2.97 3/15/2022233,000 shares $719,970.00 -14.1%2.7%2.3 $3.09 2/28/2022271,300 shares $1.01 million -8.3%3.1%2.7 $3.71 2/15/2022295,900 shares $1.19 million -8.5%3.3%2.6 $4.02 1/31/2022323,300 shares $1.34 million +8.8%4.3%2.6 $4.14 1/15/2022297,300 shares $1.56 million +14.2%4.0%2 $5.26 12/31/2021260,300 shares $1.47 million -3.6%3.5%1 $5.63 12/15/2021270,100 shares $1.44 million -21.3%3.6%0.8 $5.34 11/30/2021343,100 shares $2.17 million -5.0%4.6%0.1 $6.32 11/15/2021361,100 shares $2.48 million -27.5%4.9%0.1 $6.86 10/29/2021498,100 shares $4.09 million -16.0%6.7%0.2 $8.22 10/15/2021593,200 shares $4.63 million -6.9%8.0%0.2 $7.81 9/30/2021637,000 shares $4.70 million +333.0%8.6%0.2 $7.38 9/15/2021147,100 shares $801,695.00 +87.2%2.0%0 $5.45 8/31/202178,600 shares $461,382.00 +216.9%1.1%0.8 $5.87 8/13/202124,800 shares $113,832.00 +19.2%0.3%0.2 $4.59Warning: Prepare to Be Shocked by These Payouts (Ad)There's a strategy out there paying up to 70% on tech stocks like Amazon, Tesla, and Microsoft—stocks that don't even pay dividends. It's fast, it's legal, and most people have no clue it exists.Click here to see how much you could be collecting each month → 7/30/202120,800 shares $103,792.00 +17.5%0.3%0.2 $4.99 7/15/202117,700 shares $86,730.00 -35.6%0.2%0.1 $4.90 6/30/202127,500 shares $145,200.00 -19.4%0.4%0.2 $5.28 6/15/202134,100 shares $188,232.00 -35.2%0.5%0.2 $5.52 5/28/202152,600 shares $329,802.00 -60.1%0.7%0.3 $6.27 5/14/2021131,900 shares $774,253.00 +143.8%N/A0.5 $5.87 4/30/202154,100 shares $300,255.00 -30.7%N/A0.2 $5.55 4/15/202178,100 shares $426,426.00 -11.9%N/A0.1 $5.46 3/31/202188,600 shares $465,150.00 +180.4%N/A0.1 $5.25 3/15/202131,600 shares $176,960.00 -88.2%0.5%0.1 $5.60 2/26/2021268,800 shares $1.78 million +202.0%4.7%0.5 $6.61 2/12/202189,000 shares $623,890.00 -49.7%2.2%0.2 $7.01 1/29/2021176,900 shares $999,485.00 +784.5%4.5%0.4 $5.65 1/15/202120,000 shares $99,000.00 +34.2%0.5%0 $4.95 12/31/202014,900 shares $64,368.00 -39.4%0.4%0.1 $4.32 12/15/202024,600 shares $122,505.54 -13.7%0.8%0.2 $4.98 11/30/202028,500 shares $150,195.00 -43.7%0.9%0.2 $5.27 11/15/202050,600 shares $271,216.00 -1.9%1.7%0.2 $5.36 10/30/202051,600 shares $323,532.00 -32.6%1.7%0.2 $6.27 10/15/202076,500 shares $569,160.00 -21.8%2.5%0.1 $7.44 9/30/202097,800 shares $789,246.00 +36.0%3.2%0.1 $8.07 9/15/202071,900 shares $504,738.00 -31.5%2.5%0.1 $7.02 8/31/2020104,900 shares $978,717.00 +28.1%3.2%0.1 $9.33 8/14/202081,900 shares $573,300.00 +7.8%2.8%0 $7.00 7/31/202076,000 shares $520,600.00 +46.4%2.8%0 $6.85 7/15/202051,900 shares $244,449.00 -30.2%1.9%0 $4.71 6/30/202074,400 shares $360,096.00 +1,330.8%2.8%0.1 $4.84 6/15/20205,200 shares $30,160.00 -62.3%0.2%0 $5.80 5/29/202013,800 shares $42,366.00 -37.8%0.5%0.2 $3.07 EDSA Short Interest - Frequently Asked Questions What is Edesa Biotech's current short interest? Short interest is the volume of Edesa Biotech shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 41,000 shares of EDSA short. 0.68% of Edesa Biotech's shares are currently sold short. Learn More on Edesa Biotech's current short interest. What is a good short interest percentage for Edesa Biotech? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.68% of Edesa Biotech's floating shares are currently sold short. Is Edesa Biotech's short interest increasing or decreasing? Edesa Biotech saw a drop in short interest in the month of April. As of April 30th, there was short interest totaling 41,000 shares, a drop of 24.8% from the previous total of 54,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Edesa Biotech's float size? Edesa Biotech currently has issued a total of 7,023,000 shares. Some of Edesa Biotech's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Edesa Biotech currently has a public float of 6,060,000 shares. How does Edesa Biotech's short interest compare to its competitors? 0.68% of Edesa Biotech's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Edesa Biotech: Precision BioSciences, Inc. (22.45%), Ikena Oncology, Inc. (0.93%), Karyopharm Therapeutics Inc. (25.06%), Renovaro Inc. (6.45%), Outlook Therapeutics, Inc. (17.45%), PepGen Inc. (8.24%), Shattuck Labs, Inc. (3.97%), ImmuCell Co. (0.11%), Verrica Pharmaceuticals Inc. (2.93%), OKYO Pharma Limited (0.74%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Edesa Biotech stock? Short selling EDSA is an investing strategy that aims to generate trading profit from Edesa Biotech as its price is falling. EDSA shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Edesa Biotech? A short squeeze for Edesa Biotech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EDSA, which in turn drives the price of the stock up even further. How often is Edesa Biotech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EDSA, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Precision BioSciences Short Interest Data Ikena Oncology Short Interest Data Karyopharm Therapeutics Short Interest Data Renovaro Short Interest Data Outlook Therapeutics Short Interest Data PepGen Short Interest Data Shattuck Labs Short Interest Data ImmuCell Short Interest Data Verrica Pharmaceuticals Short Interest Data OKYO Pharma Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:EDSA) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Prophet's Newest PredictionA storm is brewing in the markets: new tariffs, recession warnings, and panic in the headlines. That’s when pu...Stansberry Research | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored🚨 Nvidia Just Inked a $7B AI Deal—This Could Change EverythingOn Wednesday, Nvidia stock surged—again. Why? Because Saudi Arabia just announced a multi-billion-dollar AI...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Edesa Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Edesa Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
